Atlas Trials

Hydroxychloroquine and Nitazoxanide Combination Therapy for COVID-19

Clinical trial NCT04361318 · UNKNOWN

Trial details

NCT number
NCT04361318
Sponsor
Tanta University
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
COVID-19
Start date
2020-05-01
Primary completion
2020-10-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.